FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Progesterone Injection, USP
Status: Resolved
»Duration of Shortage: 12/21/2017 - 09/23/2019
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.) (Revised 09/23/2019)

Company Contact Information:
888-238-7880

Presentation
  • 500 mg/10 mL multiple dose vial (NDC 55150-306-10)
Note:
  • N/A

Fresenius Kabi USA, LLC (Revised 09/23/2019)

Company Contact Information:
888-386-1300

Presentation
  • 500 mg per 10 mL, MDV (NDC 63323-0261-10)
Note:
  • N/A

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 09/23/2019)

Company Contact Information:
800-631-2174

Presentation
  • 50 mg/mL, 10 mL (NDC 0143-9725-01)
Note:
  • N/A

Teva Pharmaceuticals (Revised 09/23/2019)

Company Contact Information:
800-545-8800

Presentation
  • 50MG 1X10ML (NDC 0591-3128-79)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English